Skip NavigationSkip to Content

Two independent routes of post-translational chemistry in fluorescent protein FusionRed

  1. Author:
    Muslinkina,Liya
    Pletnev, Vladimir Z
    Pletneva, Nadya V
    Ruchkin, Dmitry A
    Kolesov, Danila V
    Bogdanov, Alexey M
    Kost, Lubov A
    Rakitina, Tatiana V
    Agapova, Yulia K
    Shemyakina, Irina I
    Chudakov, Dmitry M
    Pletnev, Sergei
  2. Author Address

    Basic Science Program, Frederick National Laboratory for Cancer Research, Argonne, IL 60439, USA., Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia., National Research Center "Kurchatov Institute," Moscow, Russia., Basic Science Program, Frederick National Laboratory for Cancer Research, Argonne, IL 60439, USA. Electronic address: pletnevs@anl.gov.,
    1. Year: 2020
    2. Date: JUL 15
    3. Epub Date: 2020 03 31
  1. Journal: International journal of biological macromolecules
    1. 155
    2. Pages: 551-559
  2. Type of Article: Article
  3. ISSN: 0141-8130
  1. Abstract:

    The crystal structure of monomeric red fluorescent protein FusionRed (lambda(ex)/lambda(em) 580/608 mn) has been determined at 1.09 A resolution and revealed two alternative routes of post-translational chemistry, resulting in distinctly different products. The refinement occupancies suggest the 60:40 ratio of the mature Met63-Tyr64-Gly65 chromophore and uncyclized chromophore-forming tripeptide with the protein backbone cleaved between Met63 and the preceding Phe62 and oxidized C alpha-C beta bond of Tyr64. We analyzed the structures of FusionRed and several related red fluorescent proteins, identified structural elements causing hydrolysis of the peptide bond, and verified their impact by single point mutagenesis. These findings advance the understanding of the post-translational chemistry of GFP-like fluorescent proteins beyond the canonical cyclizationdehydration-oxidation mechanism. They also show that impaired cyclization does not prevent chromophore-forming tripeptide from further transformations enabled by the same set of catalytic residues. Our mutagenesis efforts resulted in inhibition of the peptide backbone cleavage, and a FusionRed variant with similar to 30% improved effective brightness. (C) 2020 Elsevier B.V. All rights reserved.

    See More

External Sources

  1. DOI: 10.1016/j.ijbiomac.2020.03.244
  2. PMID: 32243936
  3. PII : S0141-8130(20)32831-2

Library Notes

  1. Fiscal Year: FY2019-2020
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel